IPO Summary: Beta Bionics, Metsera mark major winners in IPO Market Rebound
Following the disappointing debut of Venture Global (VG), the IPO market needed a boost and got it in the healthcare sector. Beta Bionics Inc. (BBNX), a company that developed a device to improve the health and quality of life of insulin-dependent individuals with diabetes, priced 12.0 million shares at $17.00—both the size and price were revised[…]
